Login to Your Account



Drugging the undruggable

Fogpharma goes mini for maxi therapeutic effect

By Marie Powers
News Editor

Thursday, May 17, 2018

Prolific researcher, serial entrepreneur and investor Gregory Verdine nailed another nameplate to his wall with the formal introduction of 2016 startup Fog Pharmaceuticals Inc. (Fogpharma) in conjunction with the close of a $66 million series B. The round was led by 6 Dimensions Capital with participation from additional new investors GV (formerly Google Ventures), Blue Pool Capital, Horizons Ventures, Nan Fung Group and Leerink Partners. Existing investors Deerfield Management, Boyu Capital, Wuxi Apptec Corporate Ventures and undisclosed international noninstitutional investors joined the round.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription